398473-34-2,MFCD05974930
Catalog No.:AA00C9EL

398473-34-2 | JNJ 5207852 dihydrochloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
99+%
in stock  
$17.00   $12.00
- +
5mg
99+%
in stock  
$42.00   $29.00
- +
10mg
99+%
in stock  
$62.00   $43.00
- +
25mg
99+%
in stock  
$104.00   $73.00
- +
50mg
99+%
in stock  
$175.00   $123.00
- +
100mg
95%
in stock  
$331.00   $232.00
- +
250mg
95%
in stock  
$506.00   $354.00
- +
1g
95%
in stock  
$1,231.00   $862.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00C9EL
Chemical Name:
JNJ 5207852 dihydrochloride
CAS Number:
398473-34-2
Molecular Formula:
C20H32N2O
Molecular Weight:
316.4809
MDL Number:
MFCD05974930
SMILES:
C1CCN(CC1)CCCOc1ccc(cc1)CN1CCCCC1
Properties
Computed Properties
 
Complexity:
303  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
7  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.8  

Literature

Title: Radiofluorinated histamine H₃ receptor antagonist as a potential probe for in vivo PET imaging: radiosynthesis and pharmacological evaluation.

Journal: Bioorganic & medicinal chemistry 20120501

Title: Novel and highly potent histamine H3 receptor ligands. Part 2: exploring the cyclohexylamine-based series.

Journal: Bioorganic & medicinal chemistry letters 20110915

Title: Histamine H3 receptor as a drug discovery target.

Journal: Journal of medicinal chemistry 20110113

Title: Indole- and benzothiophene-based histamine H3 antagonists.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters 20100501

Title: Acidic elements in histamine H(3) receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters 20100301

Title: Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.

Journal: European journal of medicinal chemistry 20091101

Title: 5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.

Journal: Journal of medicinal chemistry 20090709

Title: Fluorinated non-imidazole histamine H3 receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters 20090415

Title: 2-Aryloxymethylmorpholine histamine H(3) antagonists.

Journal: Bioorganic & medicinal chemistry letters 20081101

Title: Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.

Journal: Bioorganic & medicinal chemistry letters 20080401

Title: Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling.

Journal: Bioorganic & medicinal chemistry 20080315

Title: Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20070901

Title: A new class of histamine H3 receptor antagonists derived from ligand based design.

Journal: Bioorganic & medicinal chemistry letters 20070701

Title: Histamine H3 receptor antagonists: from target identification to drug leads.

Journal: Biochemical pharmacology 20070415

Title: 4-[6-(2-Aminoethyl)naphthalen-2-yl]benzonitriles are potent histamine H3 receptor antagonists with high CNS penetration.

Journal: Bioorganic & medicinal chemistry letters 20070301

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Effects of histamine H(3) antagonists and donepezil on learning and mnemonic deficits induced by pentylenetetrazol kindling in weanling mice.

Journal: Neuropharmacology 20060301

Title: Aplysamine-1 and related analogs as histamine H3 receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters 20060215

Title: 4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.

Journal: Journal of medicinal chemistry 20050324

Title: 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.

Journal: Journal of medicinal chemistry 20050113

Title: Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist.

Journal: British journal of pharmacology 20041101

Title: A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines.

Journal: Journal of medicinal chemistry 20030828

Title: Barbier AJ, et al. Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br J Pharmacol. 2004 Nov;143(5):649-61.

Title: Abuhamdah RM, et al. Effects of methimepip and JNJ-5207852 in Wistar rats exposed to an open-field with and without object and in Balb/c mice exposed to a radial-arm maze. Front Syst Neurosci. 2012 Jul 16;6:54.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:398473-34-2 Molecular Formula|398473-34-2 MDL|398473-34-2 SMILES|398473-34-2 JNJ 5207852 dihydrochloride
Catalog No.: AA00C9EL
398473-34-2,MFCD05974930
398473-34-2 | JNJ 5207852 dihydrochloride
Pack Size: 1mg
Purity: 99+%
in stock
$17.00 $12.00
Pack Size: 5mg
Purity: 99+%
in stock
$42.00 $29.00
Pack Size: 10mg
Purity: 99+%
in stock
$62.00 $43.00
Pack Size: 25mg
Purity: 99+%
in stock
$104.00 $73.00
Pack Size: 50mg
Purity: 99+%
in stock
$175.00 $123.00
Pack Size: 100mg
Purity: 95%
in stock
$331.00 $232.00
Pack Size: 250mg
Purity: 95%
in stock
$506.00 $354.00
Pack Size: 1g
Purity: 95%
in stock
$1,231.00 $862.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00C9EL
Chemical Name: JNJ 5207852 dihydrochloride
CAS Number: 398473-34-2
Molecular Formula: C20H32N2O
Molecular Weight: 316.4809
MDL Number: MFCD05974930
SMILES: C1CCN(CC1)CCCOc1ccc(cc1)CN1CCCCC1
Properties
Complexity: 303  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 23  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 7  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.8  
Literature fold

Title: Radiofluorinated histamine H₃ receptor antagonist as a potential probe for in vivo PET imaging: radiosynthesis and pharmacological evaluation.

Journal: Bioorganic & medicinal chemistry20120501

Title: Novel and highly potent histamine H3 receptor ligands. Part 2: exploring the cyclohexylamine-based series.

Journal: Bioorganic & medicinal chemistry letters20110915

Title: Histamine H3 receptor as a drug discovery target.

Journal: Journal of medicinal chemistry20110113

Title: Indole- and benzothiophene-based histamine H3 antagonists.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters20100501

Title: Acidic elements in histamine H(3) receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters20100301

Title: Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.

Journal: European journal of medicinal chemistry20091101

Title: 5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.

Journal: Journal of medicinal chemistry20090709

Title: Fluorinated non-imidazole histamine H3 receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters20090415

Title: 2-Aryloxymethylmorpholine histamine H(3) antagonists.

Journal: Bioorganic & medicinal chemistry letters20081101

Title: Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.

Journal: Bioorganic & medicinal chemistry letters20080401

Title: Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling.

Journal: Bioorganic & medicinal chemistry20080315

Title: Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.

Journal: Bioorganic & medicinal chemistry letters20070901

Title: A new class of histamine H3 receptor antagonists derived from ligand based design.

Journal: Bioorganic & medicinal chemistry letters20070701

Title: Histamine H3 receptor antagonists: from target identification to drug leads.

Journal: Biochemical pharmacology20070415

Title: 4-[6-(2-Aminoethyl)naphthalen-2-yl]benzonitriles are potent histamine H3 receptor antagonists with high CNS penetration.

Journal: Bioorganic & medicinal chemistry letters20070301

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Effects of histamine H(3) antagonists and donepezil on learning and mnemonic deficits induced by pentylenetetrazol kindling in weanling mice.

Journal: Neuropharmacology20060301

Title: Aplysamine-1 and related analogs as histamine H3 receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters20060215

Title: 4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.

Journal: Journal of medicinal chemistry20050324

Title: 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.

Journal: Journal of medicinal chemistry20050113

Title: Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist.

Journal: British journal of pharmacology20041101

Title: A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines.

Journal: Journal of medicinal chemistry20030828

Title: Barbier AJ, et al. Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br J Pharmacol. 2004 Nov;143(5):649-61.

Title: Abuhamdah RM, et al. Effects of methimepip and JNJ-5207852 in Wistar rats exposed to an open-field with and without object and in Balb/c mice exposed to a radial-arm maze. Front Syst Neurosci. 2012 Jul 16;6:54.

Building Blocks More >
3868-03-9
3868-03-9
1,6:2,3-Dianhydro-beta-d-mannopyranose
AA00C9LY | MFCD18643031
41717-32-2
41717-32-2
1-Benzofuran-2-carbonitrile
AA00C9RL | MFCD01659779
42952-91-0
42952-91-0
N-NitrosodiphenylaMine-d10
AA00C9Z4 | MFCD00144988
382-94-5
382-94-5
3-BROMO-1,1,1-TRIFLUORO-PENTAN-2-ONE
AA00CAA3 | MFCD08275467
331765-71-0
331765-71-0
3,5-Difluoro-2-nitrobenzoic acid
AA00CAPO | MFCD04035649
21472-86-6
21472-86-6
3,4,5-Trichlorotoluene
AA00CB8B | MFCD13689008
26957-73-3
26957-73-3
5-(2-Hydroxy-ethyl)-[1,3,5]triazinane-2-thione
AA00CDWK | MFCD00054551
210992-56-6
210992-56-6
2-Fluoro-3-(methylthio)pyridine
AA00CFUE | MFCD22543684
289688-87-5
289688-87-5
2-Methoxy-6-methylpyridin-3-ol
AA00CH3S | MFCD16611373
41966-94-3
41966-94-3
(3,3-dimethylbutyl)triethoxysilane
AA00CHL8 | MFCD09909991
Submit
© 2017 AA BLOCKS, INC. All rights reserved.